# Angela D. Ritter, M.D. – FDA Inspection, Aug 17, 2023

Source: https://www.keypedia.com/records/fda_inspections/angela-d-ritter-md/59a46f17-1e8a-4e51-bc69-56db11d31f3b
Source feed: FDA_Inspections

> FDA inspection 1215162 of Angela D. Ritter, M.D., August 17, 2023. Classification: Official Action Indicated (OAI). 9 citations under 21 CFR parts 56 and 312. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1215162
- Company Name: Angela D. Ritter, M.D.
- Inspection Date: 2023-08-17
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 9
- Enforcement Type: WARNING_LETTER

## Related Officers

- [Company Rep](https://www.keypedia.com/people/ann-b-borromeo/ca03a531-043c-4195-b100-a8a0fc763159)
- [Issuing Officer](https://www.keypedia.com/people/matthew-r-coleman/6fc13ec4-a609-4c3c-961f-16cba13a3a3a)

Company: https://www.keypedia.com/companies/angela-d-ritter-md/8b7db282-7127-4db5-841e-f61792ea8116

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
